Commentary on Crawford,et al,The Role of Patch Testing in the Evaluation of Orthopedic Implant-Related Adverse Effects: Current Evidence Does Not Support Broad Use
Restricted accessResearch articleFirst published online June, 2013
Commentary on Crawford,et al,The Role of Patch Testing in the Evaluation of Orthopedic Implant-Related Adverse Effects: Current Evidence Does Not Support Broad Use
ThyssenJP, MenneT, SchalockPC, et al.Pragmatic approach to the clinical work-up of patients with putative allergic disease to metallic orthopaedic implants before and after surgery. Br J Dermatol, 2011; 164: 473–478.
2.
SchalockPC, MennéT, JohansenJD, et al.Hypersensitivity reactions to metallic implants—diagnostic algorithm and suggested patch test series for clinical use. Contact Dermatitis, 2012; 66: 4–19.
3.
HonariG, EllisSG, WilkoffBL, et al.Hypersensitivity reactions associated with endovascular devices. Contact Dermatitis, 2008; 59: 7–22.
4.
Atanaskova MesinkovskaN, TellezA, MolinaL, et al.The effect of patch testing on surgical practices and outcomes in orthopedic patients with metal implants. Arch Dermatol, 2012; 148: 687–693.
KurtzS, MowatF, OngK, et al.Prevalence of primary and revision total hip and knee arthroplasty in the United States from 1990 through 2002. J Bone Joint Surg Am, 2005; 87: 1487–1497.
7.
KurtzS, OngK, LauE, et al.Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am, 2007; 89: 780–785.
8.
OngKL, MowatFS, ChanN, et al.Economic burden of revision hip and knee arthroplasty in Medicare enrollees. Clin Orthop Relat Res, 2006; 446: 22–28.
9.
HallabNJ, AndersonS, CaicedoM, et al.Effects of soluble metals on human peri-implant cells. J Biomed Mater Res A, 2005; 74: 124–140.
10.
HoltG, MurnaghanC, ReillyJ, et al.The biology of aseptic osteolysis. Clin Orthop Relat Res, 2007; 460: 240–252.
UrbanRM, JacobsJJ, TomlinsonMJ, et al.Dissemination of wear particles to the liver, spleen, and abdominal lymph nodes of patients with hip or knee replacement. J Bone Joint Surg Am, 2000; 82: 457–476.
13.
MalekIA, KingA, SharmaH, et al.The sensitivity, specificity and predictive values of raised plasma metal ion levels in the diagnosis of adverse reaction to metal debris in symptomatic patients with a metal-on-metal arthroplasty of the hip. J Bone Joint Surg Br, 2012; 94: 1045–1050.
14.
SchmidtM, RaghavanB, MüllerV, et al.Crucial role for human Toll-like receptor 4 in the development of contact allergy to nickel. Nat Immunol, 2010; 11: 814–819.
15.
RaghavanB, MartinSF, EsserPR, et al.Metal allergens nickel and cobalt facilitate TLR4 homodimerization independently of MD2. EMBO Rep, 2012; 13: 1109–1115.
16.
ThomasP, SchuhA, RingJ, et al.Orthopedic surgical implants and allergies: joint statement by the implant allergy working group (AK 20) of the DGOOC (German Association Of Orthopedics and Orthopedic Surgery), DKG (German Contact Dermatitis Research Group) and DGAKI (German Society for Allergology and Clinical Immunology). Orthopade, 2008; 37: 75–88.
17.
LefebvreJS, MarleauS, MilotV, et al.Toll-like receptor ligands induce polymorphonuclear leukocyte migration: key roles for leukotriene B4 and platelet-activating factor. FASEB J, 2010; 24: 637–647.
18.
LefebvreJS, LévesqueT, PicardS, et al.Extra domain A of fibronectin primes leukotriene biosynthesis and stimulates neutrophil migration through activation of Toll-like receptor 4. Arthritis Rheum, 2011; 63: 1527–1533.
19.
LahdeojaT, PajarinenJ, KouriVP, et al.Toll-like receptors and aseptic loosening of hip endoprosthesis—a potential to respond against danger signals?. J Orthop Res, 2010; 28: 184–190.
20.
RostokerG, RobinJ, BinetO, et al.Dermatitis due to orthopaedic implants. A review of the literature and report of three cases. J Bone Joint Surg Am, 1987; 69: 1408–1412.
21.
GranchiD, CenniE, GiuntiA, et al.Metal hypersensitivity testing in patients undergoing joint replacement: a systematic review. J Bone Joint Surg Br, 2012; 94: 1126–1134.
HallabNJ, AndersonS, StaffordT, et al.Lymphocyte responses in patients with total hip arthroplasty. J Orthop Res, 2005; 23: 384–391.
24.
von KnochF, MarchieA, MalchauH. Total joint registries: a foundation for evidence-based arthroplasty. Virtual Mentor, 2010; 12: 124–129.
25.
HerbertsP, MalchauH. How outcome studies have changed total hip arthroplasty practices in Sweden. Clin Orthop Relat Res, 1997; (344): 44–60.
26.
BruzeM. Thoughts on implants and contact allergy. Arch Dermatol, 2008; 144: 1042–1044.
27.
ThyssenJP, JohansenJD, MennéT, et al.Hypersensitivity reactions from metallic implants: a future challenge that needs to be addressed. Br J Dermatol, 2010; 162: 235–236.
28.
GillHS, GrammatopoulosG, AdsheadS, et al.Molecular and immune toxicity of CoCr nanoparticles in MoM hip arthroplasty. Trends Mol Med, 2012; 18: 145–155.
29.
KubbaR, TaylorJS, MarksKE. Cutaneous complications of orthopedic implants. A two-year prospective study. Arch Dermatol, 1981; 117: 554–560.
30.
CarlssonA, MollerH. Implantation of orthopaedic devices in patients with metal allergy. Acta Derm Venereol, 1989; 69: 62–66.
